X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE WOCKHARDT LTD. SUVEN LIFE/
WOCKHARDT LTD.
 
P/E (TTM) x 16.3 -11.2 - View Chart
P/BV x 3.9 2.2 173.3% View Chart
Dividend Yield % 0.5 1.5 30.7%  

Financials

 SUVEN LIFE   WOCKHARDT LTD.
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
WOCKHARDT LTD.
Mar-17
SUVEN LIFE/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs2291,129 20.2%   
Low Rs151627 24.1%   
Sales per share (Unadj.) Rs42.7363.1 11.8%  
Earnings per share (Unadj.) Rs6.9-20.4 -33.5%  
Cash flow per share (Unadj.) Rs8.5-7.0 -122.3%  
Dividends per share (Unadj.) Rs1.0010.00 10.0%  
Dividend yield (eoy) %0.51.1 46.3%  
Book value per share (Unadj.) Rs52.4301.8 17.4%  
Shares outstanding (eoy) m127.28110.55 115.1%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.42.4 183.8%   
Avg P/E ratio x27.7-42.9 -64.5%  
P/CF ratio (eoy) x22.2-125.9 -17.7%  
Price / Book Value ratio x3.62.9 124.5%  
Dividend payout %14.6-48.9 -29.8%   
Avg Mkt Cap Rs m24,15897,063 24.9%   
No. of employees `0001.06.8 15.0%   
Total wages/salary Rs m5229,665 5.4%   
Avg. sales/employee Rs Th5,349.75,931.8 90.2%   
Avg. wages/employee Rs Th513.51,428.1 36.0%   
Avg. net profit/employee Rs Th858.1-334.0 -256.9%   
INCOME DATA
Net Sales Rs m5,43540,146 13.5%  
Other income Rs m2111,143 18.5%   
Total revenues Rs m5,64641,289 13.7%   
Gross profit Rs m1,291128 1,008.3%  
Depreciation Rs m2141,489 14.4%   
Interest Rs m572,253 2.5%   
Profit before tax Rs m1,231-2,472 -49.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m359-211 -170.0%   
Profit after tax Rs m872-2,260 -38.6%  
Gross profit margin %23.70.3 7,447.7%  
Effective tax rate %29.28.5 341.4%   
Net profit margin %16.0-5.6 -284.9%  
BALANCE SHEET DATA
Current assets Rs m4,91746,160 10.7%   
Current liabilities Rs m1,18619,258 6.2%   
Net working cap to sales %68.667.0 102.4%  
Current ratio x4.12.4 173.0%  
Inventory Days Days62101 61.7%  
Debtors Days Days3194 32.7%  
Net fixed assets Rs m3,15440,165 7.9%   
Share capital Rs m127553 23.0%   
"Free" reserves Rs m6,54332,814 19.9%   
Net worth Rs m6,67033,367 20.0%   
Long term debt Rs m25931,903 0.8%   
Total assets Rs m8,15789,687 9.1%  
Interest coverage x22.7-0.1 -23,337.5%   
Debt to equity ratio x01.0 4.1%  
Sales to assets ratio x0.70.4 148.9%   
Return on assets %11.40 -132,606.2%  
Return on equity %13.1-6.8 -193.0%  
Return on capital %18.6-0.3 -5,542.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,9969,121 54.8%   
Fx outflow Rs m9592,133 45.0%   
Net fx Rs m4,0376,988 57.8%   
CASH FLOW
From Operations Rs m1,088-2,695 -40.4%  
From Investments Rs m-3,107-6,863 45.3%  
From Financial Activity Rs m-30012,545 -2.4%  
Net Cashflow Rs m-2,3193,010 -77.0%  

Share Holding

Indian Promoters % 63.4 74.5 85.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.3 -  
FIIs % 0.0 7.7 -  
ADR/GDR % 0.0 0.1 -  
Free float % 36.5 15.4 237.0%  
Shareholders   37,287 67,757 55.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   DR. REDDYS LAB  IPCA LABS  ASTRAZENECA PHARMA  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jun 22, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS